Adventa Bhd (XKLS:7191) Equity-to-Asset: 0.81 (As of Mar. 2026) — 14% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7191 Adventa Bhd XKLS:7191
32 GF Score
Price RM0.13
GF Value RM0.24
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adventa Bhd Equity-to-Asset?

Adventa Bhd XKLS:7191 -7.14% 32 Equity-to-Asset is 0.81 as of Mar. 2026, which is 14% above its 10-year median of 0.71. GuruFocus rates XKLS:7191 with a GF Score™ of 32/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Adventa Bhd ranks better than 77.09% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Adventa Bhd's Total Stockholders Equity for the quarter that ended in Mar. 2026 was RM84.40 Mil. Adventa Bhd's Total Assets for the quarter that ended in Mar. 2026 was RM103.97 Mil. Therefore, Adventa Bhd's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.81.

The historical rank and industry rank for Adventa Bhd's Equity-to-Asset or its related term are showing as below:

XKLS:7191' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55   Med: 0.71   Max: 0.91
Current: 0.81

During the past 13 years, the highest Equity to Asset Ratio of Adventa Bhd was 0.91. The lowest was 0.55. And the median was 0.71.

XKLS:7191's Equity-to-Asset is ranked better than
77.09% of 851 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs XKLS:7191: 0.81

Adventa Bhd  (XKLS:7191) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Adventa Bhd Equity-to-Asset Related Terms


Adventa Bhd Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Adventa Bhd's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adventa Bhd Equity-to-Asset Chart

Adventa Bhd Annual Data
Trend Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.85 0.87 0.87 0.78

Adventa Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.83 0.88 0.78 0.81

XKLS:7191 vs ISRG, BDX, RMD: Equity-to-Asset Comparison

For the Medical Instruments & Supplies subindustry, Adventa Bhd's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adventa Bhd Equity-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's Equity-to-Asset falls into.


XKLS:7191
32GF Score
Adventa Bhd XKLS:7191
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adventa Bhd Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Adventa Bhd's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=86.952/111.142
=0.78

Adventa Bhd's Equity to Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

Equity to Asset (Q: Mar. 2026 )=Total Stockholders Equity/Total Assets
=84.4/103.974
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.81 mean?
Adventa Bhd (XKLS:7191) has a Equity-to-Asset of 0.81 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Adventa Bhd and its competitors. This is 14% above median its historical median of 0.71. Over the past decade, Adventa Bhd's Equity-to-Asset has ranged from 0.55 to 0.91. According to the industry distribution chart, Adventa Bhd ranks #195 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 22.9%.
Is Adventa Bhd's Equity-to-Asset too high?
Adventa Bhd's current Equity-to-Asset of 0.81 is 14% above median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 0.91. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Adventa Bhd's value of 0.81 is 26.6% above this industry median. Based on the distribution chart, Adventa Bhd ranks #195 out of 851 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Adventa Bhd has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #195 out of 851 companies for Equity-to-Asset. This places Adventa Bhd in the top 23% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.64. Adventa Bhd's value of 0.81 is 26.6% above this benchmark. Historically, Adventa Bhd's own Equity-to-Asset has ranged from 0.55 to 0.91 over the past decade. While the company's 10-year median is 0.71 vs. the industry median of 0.64, Adventa Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adventa Bhd's current Equity-to-Asset of 0.81 is 26.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Adventa Bhd and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current Equity-to-Asset is 0.81, which is 14% above median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 45.8% below its estimated fair value. The current Equity-to-Asset is 0.81, which is 14% above median its 10-year median of 0.71 and 26.6% above the Medical Devices & Instruments industry median of 0.64. Adventa Bhd's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current Equity-to-Asset is 0.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adventa Bhd (XKLS:7191) Overvalued in 2026?

Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued. The current stock price of RM0.13 is trading 45.8% below its estimated GF Value™ of RM0.24. GuruFocus considers Adventa Bhd to be Possible Value Trap.

Key valuation signals for XKLS:7191:

  • Equity-to-Asset: 0.81 (14% above median its 10-year median of 0.71)
  • GF Value™: RM0.24 vs. price of RM0.13 (45.8% below fair value)
  • GF Score™: 32/100 with 6 warning signs
  • Industry Position: 26.6% above the Medical Devices & Instruments median (#195 of 851)

No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adventa Bhd Business Description

Address No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
32GF Score

Get the complete analysis for XKLS:7191

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.13
Price
RM0.24
GF Value